ClinicalTrials.gg
CompletedNCT03843424TEAM UPUpdated Oct 1, 2024

Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers

An interventional study of eSOC program and FBT program in Obesity, Childhood, Pediatric Obesity and Childhood Obesity, sponsored by Washington University School of Medicine. Completed at 7 sites in United States. Open to participants aged 6 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-01.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
1,460
Allocation
Randomized
Ages
6 Years to 15 Years
Sex
All
01

Study summary

The US Preventive Services Task Force (USPSTF) recommends that providers screen children aged 6 years and older for obesity and offer or refer them to a comprehensive behavioral intervention (≥26 hours over a period of up to 12 months) to promote improvement in weight status. Family-based behavioral treatment (FBT) is an effective treatment that targets both child and parents and meets the USPSTF recommendations. By contrast, the American Medical Association (AMA) recommends a staged approach to childhood obesity screening and counseling, which begins with prevention counseling by the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies. Our study compares a staged approach enhanced standard of care (eSOC) vs. eSOC + FBT, to provide families and PCPs with information on the best intervention approach for the behavioral treatment of childhood obesity. Our project seeks to fill the gap in the evidence on family-based weight management in primary care settings among diverse and underserved populations with a special focus on Black children, families insured by Medicaid, and sex differences.

Read the detailed description

Note: our enrollment number includes two participants (one child and one parent) from each enrolled family.

02

Conditions studied

  • Obesity, Childhood
  • Pediatric Obesity
  • Childhood Obesity
  • Adolescent Obesity
  • Overweight
  • Overweight and Obesity
  • Overweight or Obesity
  • Overweight Adolescents
  • Weight Gain
  • Overnutrition
  • Body Weight
  • Body Weight Changes
  • Nutrition Disorders

Keywords

  • Weight Management
  • Child
  • Intervention
  • Weight Loss
  • Behavior Therapy
  • Nutrition
03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's enrollment of 1,460 is above the median of 100 across 870 interventional studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,803 studies on the registry; 271 are open to participants now.

Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for children include:

  • have a percentile ≥95th for age and sex;
  • comfortable speaking English language;
  • able to provide written or verbal (based on age) informed assent;
  • willing to change diet, physical activity, and/or weight;
  • patient of a participating clinic/practice; and
  • able to participate in scheduled sessions.

Inclusion Criteria for parents include:

  • comfortable speaking and reading English language.

Exclusion Criteria include:

  • families who plan to no longer have the child be a patient of any participating clinic/practice during any point in the 18-month study period;
  • children with chronic conditions or on medications that substantially impact or interfere with growth, appetite, weight, or physical activity participation;
  • families for whom the Primary Care Provider (PCP) or site PI thinks the intervention is clinically/medically inappropriate (e.g., developmental delay, or emotional or cognitive difficulties, if the PI/PCP believes these factors will interfere with study/intervention participation); and
  • families in whom the parent or child exhibits eating disorder symptomatology.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,460 participants (actual)

Study arms

  • Active comparator
    Enhanced Standard of Care (eSOC)

    This group will receive the eSOC program. A minimum of 6 visits to the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies.

    Behavioral: eSOC program

  • Active comparator
    Family-Based Behavioral Treatment (FBT + eSOC)

    This group will receive eSOC plus the FBT program. Family-based behavioral treatment (FBT), an effective treatment that targets both child and parents meeting regularly with a health coach for healthy eating, activity, positive parenting strategies, and managing environmental cues.

    Behavioral: eSOC program · Behavioral: FBT program

Interventions

  • BehavioraleSOC program

    American Medical Association (AMA) recommended staged approach to childhood obesity screening and counseling

  • BehavioralFBT program

    An intensive,comprehensive, behavioral intervention aligned with the US Preventive Services Task Force recommendations for childhood obesity screening and counseling.

06

What researchers measure

Primary outcomes

  1. Child percent overweight

    Time frame: 1 year

07

Study locations

7 sites
  • Washington University School of Medicine
    Alton, Illinois 62002, United States
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
  • Pennington Biomedical Research Center
    New Orleans, Louisiana 70121, United States
  • Washington University School of Medicine
    Cape Girardeau, Missouri 63703, United States
  • University of Missouri School of Medicine
    Columbia, Missouri 65201, United States
  • Washington University School of Medicine
    Saint Louis, Missouri 63110, United States
  • University of Rochester Medical Center
    Rochester, New York 14642, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2019 to primary completion in Jun 2024, 57 months.

Of 539 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 57 months is above that.

Counting every sponsor, half of 541 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 14, 2019
First posted
Feb 18, 2019
StartActual
Sep 12, 2019
Primary completionActual
Jun 26, 2024
CompletionActual
Jul 26, 2024
Last update
Oct 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03843424
Collaborators
Patient-Centered Outcomes Research Institute, Blue Cross and Blue Shield of Louisiana, American Academy of Pediatrics, Pennington Biomedical Research Center, Louisiana Healthcare Connections, Nationwide Children s Hospital in Columbus, Ohio, University of Rochester
Responsible party
Sponsor
First posted
Feb 18, 2019
Start date
Sep 12, 2019
Primary completion
Jun 26, 2024
Completion
Jul 26, 2024
Last update
Oct 1, 2024

Study contacts

Denise E. Wilfley, PhD
principal investigator · Washington University School of Medicine
Stephen Cook, MD, MPH
principal investigator · University of Rochester

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion